Briefs

CAMBRIDGE, Mass--April 9, 2002--Molecular Mining Corporation (MMC) announced the opening of their new Business Headquarters at 41 Linskey Way, in Cambridge, MA. The location will house the company's worldwide Sales, Marketing and Business development executive staff as well as becoming the home office for the US domestic sales team.

The company will be putting on a Grand Opening Open House soon to coincide with the launch of GeneLinker(TM) Platinum. GeneLinker Platinum takes microarray data analysis to the newest level of sophistication; augmenting traditional linear methods of data analysis with MMC's proprietary SLAM(TM) data mining technology that finds high-order correlations incredibly fast and uncovers the non-linear and predictive relationships that characterize disease and drug response.

Molecular Mining Corporation specializes in the exploration, inference and prediction of molecular networks derived from gene expression, proteomics and SNPs (single nucleotide polymorphisms) data, and the application of these network models to diagnostic and drug target identification, predictive toxicology and in silico drug screening.